PFA is associated with a significantly lower risk for recurrence of atrial arrhythmia compared with antiarrhythmic-drug therapy receipt.

Atrial fibrillation (AF) is becoming more common as populations age and more patients live with multiple conditions. AF remains a major cause of ...

On April 26, 2026, Medtronic announced continued momentum for the Affera family of technologies for cardiac arrhythmia ...

The future of pulsed field ablation (PFA) technology could go in the direction of high-voltage nanosecond energy bursts, ...

Electrophysiologists at UPMC Heart and Vascular Institute in Williamsport now offer pulsed field ablation (PFA), a new, ...

With CMS’ recent approval of electrophysiology ablation procedures for the ASC setting, leaders are faced with a range of new ...

Kauvery Hospital, Alwarpet, successfully completed an innovative cardiac procedure, combining MitraClip and Left Atrial ...

Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.

A major clinical trial has found Boston Scientific’s Farapulse pulsed-field ablation nearly doubles the success rate of treating persistent atrial fibrillation compared with medication. One year after ...

We also report below on early data that poses a possible solution to a devastating pregnancy complication, and a potential ...

Atrial fibrillation, often called AFib, is a condition that affects the rhythm of the heart. Instead of beating in a steady ...